Oracle's $638 Billion Backlog Is the Prize — and the Problem
Published on 08/05/2026 at 13:32 | Redaktion boerse-global.de
Oracle's shareholders have been on a white-knuckle ride. The stock surged nearly 21 percent in seven days on a wave of fresh contract announcements, then promptly stalled. Wednesday's 1.46 percent dip to €124.48 looks less like a reversal and more like a market catching its breath.
The real story sits deeper, in a backlog that has become both Oracle's proudest achievement and its most exposed flank.
A Contract Machine in Overdrive
The recent rally traces back to a burst of deal-making. On July 30, Oracle struck a partnership with Google Cloud, bundling Google's Gemini AI model into its Fusion and NetSuite software at no extra cost. Days later came a $400 million agreement with IT services firm CACI International, complementing a $7 billion defense contract signed earlier in July. Add to that a supply deal for hospitals in Ontario through the Oracle Health division, and the picture becomes clear: Oracle is stacking government and enterprise wins at a pace few rivals can match.
CACI will serve as one of Oracle's technology partners modernizing IT systems for the US Office of Personnel Management. The contract extends a portfolio that already includes a sprawling Pentagon agreement inked just weeks prior.
Should investors sell immediately? Or is it worth buying Oracle?
The Backlog That Drives Everything
Oracle's cloud infrastructure unit grew 93 percent in the latest quarter. The backlog, however, tells the more dramatic story: it jumped 363 percent year over year to $638 billion. Three names power that surge — OpenAI, Meta, and xAI — each committing to massive AI infrastructure deals.
For investors, that backlog is the bull case in its purest form. The numbers are unprecedented for the company. But they carry an uncomfortable corollary. Morningstar's analysts warn that Oracle may struggle to source enough Nvidia chips to meet demand, a supply constraint that could delay revenue recognition. New customers like OpenAI and xAI chose Oracle over AWS, Azure, or Google Cloud — a vote of confidence, but also a concentration risk.
The Balance Sheet Casts a Long Shadow
The euphoria around the backlog collides with a sobering financial reality. In July 2026, S&P Global downgraded Oracle's credit rating to BBB-, one notch above junk status. The reason is structural: Oracle is funding its AI infrastructure buildout not from a war chest of cash like its Magnificent Seven peers, but through external capital. The company plans to raise between $45 billion and $50 billion in calendar 2026 through a mix of debt and new equity. Analysts have dubbed this an "equity bazooka" — a term that barely conceals the urgency behind it.
The internal restructuring has already exacted a toll. Oracle cut roughly 21,000 positions in fiscal 2026, about 13 percent of its global workforce, with severance and wind-down costs reaching $1.84 billion. The logic is straightforward: redirect capital from legacy operations into AI-driven growth. But the strategy leaves Oracle running a leveraged race against its own interest burden.
The OpenAI Dependency
A significant portion of the backlog reportedly hinges on a single customer: OpenAI. If AI industry growth decelerates, or if a key client runs into financing trouble, Oracle could find itself holding expensive, idle data center capacity — with a debt load that becomes progressively harder to service.
The risk extends beyond Oracle. Analysts have warned that the current AI bubble may be larger than the dot-com era of the early 2000s. Should OpenAI or Anthropic stumble, a broad sell-off across hyperscalers could follow, hitting Oracle disproportionately given its reliance on those very customers.
A Stock Between Recovery and Precipice
The technical picture reflects the tension. After hitting a yearly low of €100.76 in late July, the stock recovered more than 25 percent to trade around €126.32. Yet it remains down 24 percent year to date and sits 55 percent below its all-time high of €280.70. The stock is still 19.11 percent below its 200-day moving average of €153.89 — a reminder of how deep the drawdown ran. Annualized 30-day volatility stands at 58.66 percent, signaling persistent turbulence.
Oracle at a turning point? This analysis reveals what investors need to know now.
Consensus analyst price targets sit at €215.28, implying roughly 70 percent upside from current levels. That forecast embodies a clear bet: that the cloud buildout will ultimately justify the financial strain. With a market capitalization of €324.75 billion, Oracle's valuation hangs on execution that depends on massive external financing.
Reports have also circulated that founder Larry Ellison has lost as much as $207 billion in personal wealth through the company's aggressive AI wager — a figure that underscores how much of Oracle's fate is tied to a single strategic bet.
The next catalyst arrives with the fiscal first-quarter report, still weeks away. Until then, the market will weigh whether contracts like CACI and Ontario Health can offset concerns about capital expenditures, chip shortages, and AI overvaluation. Oracle's story is no longer simply about growth. It is a leveraged wager that the company can expand faster than its debt compounds — a question that will be answered not by chart patterns, but by whether the customers behind that $638 billion backlog can actually pay.
Ad
Oracle Stock: New Analysis - 5 August
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
